Search research articles
Contact Us
Filters
Showing results (91-100 of 109) with videos related to
Page
of 11
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
February 23, 2021
Expression of Human Immunodeficiency Virus Transactivator of Transcription (HIV-Tat<sub>1-86</sub>) Protein Alters Nociceptive Processing that is Sensitive to Anti-Oxidant and Anti-Inflammatory Interventions
Thomas J Cirino, Amy R Alleyne, Vinicius Duarte, et al.
Journal of Medicinal Chemistry
|
January 9, 2020
Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity
Verrill M Norwood, Ariana C Brice-Tutt, Shainnel O Eans, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 30, 2025
Total synthesis and biological activity of "carbamorphine": O-to-CH<sub>2</sub> replacement in the E-ring of the morphine core structure
Sota Akiyama, Rohini S Ople, Alexander Kremsmair, et al.
ACS Chemical Neuroscience
|
July 2, 2021
Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom
Soumen Chakraborty, Rajendra Uprety, Amal E Daibani, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
October 24, 2017
Conditional Human Immunodeficiency Virus Transactivator of Transcription Protein Expression Induces Depression-like Effects and Oxidative Stress
Jay P McLaughlin, Jason J Paris, Dionyssios Mintzopoulos, et al.
Drug and Alcohol Dependence
|
October 5, 2020
Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence
Lisa L Wilson, Hannah M Harris, Shainnel O Eans, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2021
Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects
Ram Kandasamy, Todd M Hillhouse, Kathryn E Livingston, et al.
European Journal of Medicinal Chemistry
|
January 7, 2015
Synthesis and biological evaluations of novel endomorphin analogues containing α-hydroxy-β-phenylalanine (AHPBA) displaying mixed μ/δ opioid receptor agonist and δ opioid receptor antagonist activities
Miao Hu, Marc A Giulianotti, Jay P McLaughlin, et al.
Molecules (Basel, Switzerland)
|
July 12, 2025
Dual Opioid-Neuropeptide FF Small Molecule Ligands Demonstrate Analgesia with Reduced Tolerance Liabilities
Marco Mottinelli, V Blair Journigan, Samuel Obeng, et al.
Nature
|
July 3, 2024
A µ-opioid receptor modulator that works cooperatively with naloxone
Evan S O'Brien, Vipin Ashok Rangari, Amal El Daibani, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 109) with videos related to
Sort By:
Page
of 11
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
February 23, 2021
Expression of Human Immunodeficiency Virus Transactivator of Transcription (HIV-Tat<sub>1-86</sub>) Protein Alters Nociceptive Processing that is Sensitive to Anti-Oxidant and Anti-Inflammatory Interventions
Thomas J Cirino, Amy R Alleyne, Vinicius Duarte, et al.
Journal of Medicinal Chemistry
|
January 9, 2020
Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity
Verrill M Norwood, Ariana C Brice-Tutt, Shainnel O Eans, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 30, 2025
Total synthesis and biological activity of "carbamorphine": O-to-CH<sub>2</sub> replacement in the E-ring of the morphine core structure
Sota Akiyama, Rohini S Ople, Alexander Kremsmair, et al.
ACS Chemical Neuroscience
|
July 2, 2021
Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom
Soumen Chakraborty, Rajendra Uprety, Amal E Daibani, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
October 24, 2017
Conditional Human Immunodeficiency Virus Transactivator of Transcription Protein Expression Induces Depression-like Effects and Oxidative Stress
Jay P McLaughlin, Jason J Paris, Dionyssios Mintzopoulos, et al.
Drug and Alcohol Dependence
|
October 5, 2020
Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence
Lisa L Wilson, Hannah M Harris, Shainnel O Eans, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2021
Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects
Ram Kandasamy, Todd M Hillhouse, Kathryn E Livingston, et al.
European Journal of Medicinal Chemistry
|
January 7, 2015
Synthesis and biological evaluations of novel endomorphin analogues containing α-hydroxy-β-phenylalanine (AHPBA) displaying mixed μ/δ opioid receptor agonist and δ opioid receptor antagonist activities
Miao Hu, Marc A Giulianotti, Jay P McLaughlin, et al.
Molecules (Basel, Switzerland)
|
July 12, 2025
Dual Opioid-Neuropeptide FF Small Molecule Ligands Demonstrate Analgesia with Reduced Tolerance Liabilities
Marco Mottinelli, V Blair Journigan, Samuel Obeng, et al.
Nature
|
July 3, 2024
A µ-opioid receptor modulator that works cooperatively with naloxone
Evan S O'Brien, Vipin Ashok Rangari, Amal El Daibani, et al.
Page
of 11